Publications

Patent

Fn14 binding proteins and the uses thereof: WO/2013/026099, AU 2012300191, US 13/851,153

Publications

Johnston AJ and Hoogenraad NJ (2016) Fn14: a new player in cancer-induced cachexia, Curr Opin Clin Nutr Metab Care, 19(4): 316-18.

Johnston AJ, Murphy KT, Jenkinson L, Laine D, Emmrich K, Faou P, Weston R, Jayatilleke KM, Schloegel J, Talbo G, Casey JL, Levinna V, Wong WW-L, Dillon H, Sahay T, Hoogenraad J, Anderton H, Hall C, Schneider P, Tanzer M, Foley M, Scott AM, Gregorevic P, Lui SY, Burkly LC, Lynch GS, Silke J and Hoogenraad NJ (2015) Targeting of Fn14 prevents cancer-induced cachexia and prolongs survival, Cell, 162(6): 1365-78.

Patel KK, Poon IK, Talbo GH, Perugini MA, Taylor NL, Ralph TJ, Hoogenraad NJ and Hulett MD (2013) A new method for purifying histidine-rich glycoprotein from human plasma redefines its functional properties, IUBMB Life, 65(6): 550-63.

Ramasamy MS, Kulasekera R, Srikrishnaraj KA, Hoogenraad JM, Hoogenraad NJ and Ramasamy R (2013) Monoclonal antibodies to Anopheles tesellatus midgut, J Nat Sci Foundation of Sri Lanka, 23: 17-24.

Faou P and Hoogenraad NJ (2012) Tom 34: A cytosolic cochaperone of the Hsp90/Hsp70 protein complex involved in mitochondrial protein import, Biochim Biophys Acta Mol Cell Res., 1823(2): 348-57.